Girish Vasudeorao Kumthekar & Rajasekara Chakravarthi Madarasu 2022. Utility of Testing Fibroblast Growth Factor 23 in Patients with Chronic Kidney Disease: A Single Center Experience. Issues and Developments in Medicine and Medical Research Vol. 7. (Feb. 2022), 119–127. DOI:https://doi.org/10.9734/bpi/idmmr/v7/3374E.